Manifold Bio, a brand new startup based by considered one of Boston’s most prolific biotech entrepreneurs, has raised $40 million to develop a expertise that would make testing most cancers medicine extra environment friendly. The corporate is designing a system for “barcoding” protein therapies — giving them a novel label in order that dozens or a whole lot of them could be examined on the identical time to see that are greatest at focusing on tumors.
The startup was initially based in 2019 by George Church, a professor at Harvard Medical College, and two of his former graduate college students, Gleb Kuznetsov and Pierce Ogden, who are actually chief govt and chief scientific officer of the corporate.
